Presentation TCT 2013 You Want to Improve Outcomes in DES Patients? The Right Pharmacotherapy Is More Important Than the Right Stent! Presenter: Gregg Stone October 28, 2013
Presentation TCT 2013 Early Clinical Results Using the Apica TA-TAVR Device Presenter: Thomas Walther October 28, 2013
Presentation TCT 2013 Case #1: An Antegrade Success that Changed My Practice Presenter: Stephen Cook October 28, 2013
Presentation TCT 2013 Prognostic Implications of Quantitative Ischemia in Stable Ischemic Heart Disease: Lessons from SPECT, PET, and FFR Presenter: Leslee Shaw October 28, 2013
Presentation TCT 2013 Anticoagulation and Antiplatelet Regimens After TAVR: Bivalirudin (BRAVO 2/3 Trial) and Other Alternatives Presenter: George Dangas October 28, 2013
Presentation TCT 2013 Institutional Benefits of a CTO Program Presenter: James Hermiller Jr October 28, 2013
Presentation TCT 2013 Editorial Comment: LAA Exclusion: Anatomical Considerations, Device Selection and Outcomes Presenter: Juan Granada October 28, 2013